Bleeding Incidences in Atrial Fibrillation Patients Treated with Dabigatran, Rivaroxaban, or Warfarin: A Population-Based Study
Randomized controlled trials have indicated similar bleeding rates for dabigatran, rivaroxaban, and warfarin. This study aims to evaluate the real-world incidence of bleeding in patients with atrial fibrillation (AF) initiating treatment with these a...